TNXP
Tonix Pharmaceuticals Holding CorpNASDAQ
Healthcare • Biotechnology
Factor tilt: Micro-Cap Value
$4.74+3.04%
Close Nov 6, 2026
- Market cap
- $75.56M
- 1 month
- -34.9%
- 3 months
- -62.4%
- 1 year
- -73.8%
- 52-week range
- $4.60$19.89
- Dividend
- No payments on record
- Next-quarter EPS estimate
- -$2.24Quarter to Sep 30, 2026 · 3 analysts · revenue $16.32M
- Short interest
- 20.8% of float2.9M shares · settled Oct 15, 2026 · +0.1% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $29.1M
- Net income
- -$159.67M
- Free cash flow
- -$159.89M
- Book value
- $222.28M
- Total debt
- $1.27M
- P/E
- —
- Price / sales
- 2.6×
- Price / book
- 0.3×
- FCF yield
- -211.6%
- Net margin
- -548.6%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia.
Read more
It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingual tablet for the treatment of major depressive disorder and acute stress reaction/acute stress disorder; TNX-1300, a double-mutant cocaine esterase for the treatment of cocaine intoxication; TNX-1500, an Fc-modified humanized monoclonal antibody to prevent kidney transplant rejection, as well as to treat autoimmune conditions; TNX-4800, a humanized monoclonal antibody for the seasonal prevention of Lyme disease; and TNX-2900, an intranasal oxytocin potentiated with magnesium for the treatment of Prader-Willi syndrome. Further, it is developing TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, and arginine-vasopressin deficiency; TNX-801, a live horsepox vaccine for the prevention of smallpox and mpox; TNX-4200, a small molecule broad-spectrum antiviral agent targeting CD45 for the treatment or prevention of viral disease; TNX-4900, a highly selective small-molecule Sigma-1 receptor antagonist for neuropathic pain; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; and TNX-1800 and TNX-1850, live modified horsepox vaccines for the prevention of COVID. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in Berkeley Heights, New Jersey.
- Website
- tonixpharma.com
- Headquarters
- Berkeley Heights, NJ, United States
- Employees
- 142
- Listed
- May 10, 2012
- Fiscal year ends
- December
Company profile from EODHD, stored Oct 26, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 10, 2026 | $13.5M | +577.9% | 94.8% | -$42.5M | -$40.6M |
| Mar 2026filed May 11, 2026 | $6.9M | +183.2% | 69.0% | -$41.5M | -$40.2M |
| Dec 2025filed Mar 12, 2026 | $5.4M | +108.8% | 71.3% | -$48.3M | -$46.9M |
| Sep 2025filed Nov 10, 2025 | $3.3M | +16.6% | 58.4% | -$33.1M | -$32.0M |
| Jun 2025filed Aug 11, 2025 | $2.0M | -9.5% | -63.8% | -$28.3M | -$28.3M |
| Mar 2025filed May 12, 2025 | $2.4M | -2.1% | 61.2% | -$16.1M | -$16.8M |
| Dec 2024filed Mar 18, 2025 | $2.6M | -31.7% | 54.2% | -$22.5M | -$22.1M |
| Sep 2024filed Nov 12, 2024 | $2.8M | -29.3% | 44.9% | -$15.6M | -$14.2M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched TNXP. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
2,940,708 shares short
+3,209 shares (+0.1%) vs Sep 30, 2026
20.8% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
2,937,499 shares short
+99,080 shares (+3.5%) vs Sep 15, 2026
20.8% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,838,419 shares short
-263,597 shares (-8.5%) vs Aug 31, 2026
17.8% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
3,102,016 shares short
-306,114 shares (-9%) vs Aug 14, 2026
19.5% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
3,408,130 shares short
-193,287 shares (-5.4%) vs Jul 31, 2026
21.4% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
3,601,417 shares short
+16,876 shares (+0.5%) vs Jul 15, 2026
22.6% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind TNXP’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
1 for 100 · reverse split
Effective Feb 5, 2025
Each 100 pre-split shares become 1 post-split share.
Source: EODHD
1 for 32 · reverse split
Effective Jun 10, 2024
Each 32 pre-split shares become 1 post-split share.
Source: EODHD
4 for 25 · reverse split
Effective May 10, 2023
Each 25 pre-split shares become 4 post-split shares.
Source: EODHD
1 for 32 · reverse split
Effective May 17, 2022
Each 32 pre-split shares become 1 post-split share.
Source: EODHD
1 for 10 · reverse split
Effective Nov 1, 2019
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 10 · reverse split
Effective Nov 28, 2018
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if TNXP is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
8 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: buy 68 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 2
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
102 filers reported a long position in TNXP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
74.4%
of the 9.4M shares 13-F filers reported
Moves vs Q1 2026
9 added0 trimmed
1 new
Net shares held
+105.8%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $17.8M · 1.4M shares | 1.4M | +44.4% |
| 2 | Point72 Asset Management, L.P. | $14.9M · 1.2M shares | 1.2M | +830.3% |
| 3 | MILLENNIUM MANAGEMENT LLC | $12.3M · 966.9K shares | 966.9K | +340.2% |
| 4 | AQR CAPITAL MANAGEMENT LLC | $11.3M · 882.6K shares | 882.6K | +447.5% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $8.8M · 691.9K shares | 691.9K | +33.4% |
| 6 | Jones Hill Capital LP | $8M · 625.4K shares | 625.4K | +38.3% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $5M · 395.3K shares | 395.3K | +26.2% |
| 8 | Ishara Investments LP | $4.3M · 338.3K shares | 338.3K | New |
| 9 | STATE STREET CORP | $3.5M · 271.4K shares | 271.4K | +17.7% |
| 10 | UBS Group AG | $3M · 231.7K shares | 231.7K | 0% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of TNXP file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 14, 2026 | Sirenia Capital Management LP13G · passive · amended | 4.9%under 5% |
| Aug 13, 2026 | AQR CAPITAL MANAGEMENT LLC13G · passive | 5.54% |
| Jun 15, 2026 | MILLENNIUM MANAGEMENT LLC13G · passive | 5.6% |
| May 15, 2026 | Point72 Asset Management, L.P.13G · passive · amended | 6.9% |
| Mar 27, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Get the Full Analysis for TNXP
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.